Market Overview

Icahn Says Ackman Is 'Just Dead Wrong' On Herbalife

Icahn Says Ackman Is 'Just Dead Wrong' On Herbalife
Related HLF
10/10 Research Claims Herbalife May Be Attached To Brazilian Money-Laundering Complaint
Watch These 7 Huge Call Purchases In Friday Trade
Chipotle: Demand For Its Disgusting Gristly Meat Drops (Seeking Alpha)
Related VRX
Citron's Andrew Left Likes Amazon, Says He's Long
Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
Novartis: Peak Patent Exposure Offers Opportunity (Seeking Alpha)

Bill Ackman's Pershing Square hedge fund is having a rough year given its heavy losses in Valeant Pharmaceuticals Intl Inc (NYSE: VRX) and its short thesis on Herbalife Ltd. (NYSE: HLF), which has risen 110 percent since initiating a short position back in December 2012.

The last thing Ackman needs right now is to be kicked while he is down .

Icahn did exactly that when he was a guest on CNBC Thursday.

Related Link: Dennis Gartman Plays Dr. Phil And Analyzes Bill Ackman's Fall Into Oblivion

The billionaire investor said in an interview that Ackman was "completely and totally wrong" on Herbalife. He followed up with another kick that Ackman was "just dead wrong."

"This company [Herbalife] creates work for a lot of people," Icahn said. "And to say it doesn't is ridiculous."

Icahn did acknowledge Ackman is a "smart guy" even though he previously described him as a "crybaby in the schoolyard" back in 2014. Since then, the billionaire investors settled their feud and hugged it out at CNBC's 2014 Delivering Alpha Conference.

Shares of Herbalife were trading lower by around 0.50 percent Tuesday at $61.35, but are higher by nearly 15 percent since the start of 2016.

Posted-In: Bill Ackman Bill Ackman Herbalife Carl Icahn Herbalife CNBCCNBC Hedge Funds Media General Best of Benzinga


Related Articles (HLF + VRX)

View Comments and Join the Discussion!